Paper418183
Isolation and metastatic properties of detachment variants of B16 melanoma cells.
Briles EB and 1 other. J Natl Cancer Inst, 1978. Cited by 95 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation and metastatic properties of detachment variants of B16 melanoma cells. Papers, record 418183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/418183
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Separation | Major topic |
| Melanoma | Major topic |
| Neoplasm Metastasis | Major topic |
| Animals | |
| Cell Adhesion | |
| Clone Cells | |
| Edetic Acid | |
| Lung Neoplasms | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasms, Experimental |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36934257 | Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36934257 | PubMed |
| 33106502 | Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. | Nat Commun | 2020 | https://conductscience.org/library/papers/33106502 | PubMed |
| 31462854 | Rodent Glioma Models: Intracranial Stereotactic Allografts and Xenografts. | Neuromethods | 2012 | https://conductscience.org/library/papers/31462854 | PubMed |
| 28979841 | Evaluation of the metastatic potential of malignant cells by image processing of digital holographic microscopy data. | FEBS Open Bio | 2017 | https://conductscience.org/library/papers/28979841 | PubMed |
| 26646180 | Near-infrared photoactivatable control of Ca(2+) signaling and optogenetic immunomodulation. | Elife | 2015 | https://conductscience.org/library/papers/26646180 | PubMed |
| 25563824 | Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models. | Invest New Drugs | 2015 | https://conductscience.org/library/papers/25563824 | PubMed |
| 25426116 | The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy. | Front Immunol | 2014 | https://conductscience.org/library/papers/25426116 | PubMed |
| 25229620 | Anti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor models. | PLoS One | 2014 | https://conductscience.org/library/papers/25229620 | PubMed |
| 24810425 | CCL21 Cancer Immunotherapy. | Cancers (Basel) | 2014 | https://conductscience.org/library/papers/24810425 | PubMed |
| 20610625 | AACR centennial series: the biology of cancer metastasis: historical perspective. | Cancer Res | 2010 | https://conductscience.org/library/papers/20610625 | PubMed |
| 15235770 | Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. | Diabetologia | 2004 | https://conductscience.org/library/papers/15235770 | PubMed |
| 8281612 | EGF receptor in neoplasia and metastasis. | Cancer Metastasis Rev | 1993 | https://conductscience.org/library/papers/8281612 | PubMed |
| 7459211 | Malignant properties and DNA content of daughter clones from a mouse fibrosarcoma: differentiation between malignant properties. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7459211 | PubMed |
| 7435542 | In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. | Am J Pathol | 1980 | https://conductscience.org/library/papers/7435542 | PubMed |
| 7185418 | Chemotaxis of metastatic tumor cells. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/7185418 | PubMed |
| 6934525 | Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6934525 | PubMed |
| 6764376 | Experimental systems for analysis of the malignant phenotype. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6764376 | PubMed |
| 6616441 | The selective nature of metastasis. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6616441 | PubMed |
| 6607103 | Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6607103 | PubMed |
| 6208169 | Fourier analysis of the shape of normal and transformed epithelial cells derived from human transitional epithelium. | Histochemistry | 1984 | https://conductscience.org/library/papers/6208169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/418183
GET https://conductscience.org/api/papers/v1/418183/cited_by?page=2